We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+6.45%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$412M
AUM Growth
+$20.9M
Cap. Flow
-$6.64M
Cap. Flow %
-1.61%
Top 10 Hldgs %
58.04%
Holding
34
New
6
Increased
9
Reduced
14
Closed
4

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$33.1M
2
CVS icon
CVS Health
CVS
+$15.6M
3
MDT icon
Medtronic
MDT
+$8.17M
4
BIO icon
Bio-Rad Laboratories Class A
BIO
+$7.4M
5
ALKS icon
Alkermes
ALKS
+$5.2M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALKS icon
26
Alkermes
ALKS
$8.62B
$5.55M 1.35%
+200,000
New +$5.2M
RARE icon
27
Ultragenyx Pharmaceutical
RARE
$2.81B
$4.9M 1.19%
102,490
-12,676
-11% -$491K
ABT icon
28
Abbott
ABT
$177B
$4.39M 1.07%
+39,876
New +$3.98M
LNTH icon
29
Lantheus
LNTH
$6.8B
$3.24M 0.79%
52,316
+1,354
+3% +$91.7K
VIR icon
30
Vir Biotechnology
VIR
$1.56B
$1.49M 0.36%
148,538
AMED
31
DELISTED
Amedisys
AMED
-24,585
Closed -$2.3M
BDX icon
32
Becton Dickinson
BDX
$42.6B
-71,884
Closed -$18.6M
KVUE icon
33
Kenvue
KVUE
$36.5B
-144,017
Closed -$2.89M
CTLT
34
DELISTED
CATALENT, INC.
CTLT
-207,129
Closed -$9.43M

Similar funds

Sector Gamma AS's Q4 2023 Portfolio in Review

As of Q4 2023, Sector Gamma AS held 34 positions worth $412M, up 5.3% from $391M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Sector Gamma AS's Q4 2023 filing shows 6 new, 9 increased, 14 reduced and 4 closed positions. Its largest new stake was Pfizer: 1,093,416 shares worth $31.5M. The largest sale was Gilead Sciences, an estimated $18.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier, followed by Consumer Staples.

  • Sector Gamma AS's largest Q4 2023 buy was Pfizer: 1,093,416 shares worth $31.5M.
  • Sector Gamma AS added most to Medtronic in Q4 2023, an estimated $8.17M increase.
  • Sector Gamma AS's biggest Q4 2023 reduction was Gilead Sciences, cutting an estimated $18.7M.
  • Sector Gamma AS fully exited Becton Dickinson in Q4 2023, selling an estimated $18.6M.
  • Sector Gamma AS's ten largest holdings make up 58% of its $412M portfolio in Q4 2023.
  • Sector Gamma AS opened 6 new positions and closed 4 in Q4 2023.
  • Sector Gamma AS's portfolio value rose 5.3% quarter-over-quarter to $412M.

Based on Sector Gamma AS's 13F filing for Q4 2023, filed 5 Feb 2024.